{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:08:35Z","timestamp":1772755715420,"version":"3.50.1"},"reference-count":24,"publisher":"Japan Society for Clinical Immunology","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. J. Clin. Immunol.","Jpn.J.clin.Immun"],"published-print":{"date-parts":[[2013]]},"DOI":"10.2177\/jsci.36.478","type":"journal-article","created":{"date-parts":[[2013,12,30]],"date-time":"2013-12-30T23:13:13Z","timestamp":1388445193000},"page":"478-483","source":"Crossref","is-referenced-by-count":10,"title":["Successful treatment of glucocorticoid and cyclosporine refractory adult-onset Still's disease complicated with hemophagocytic syndrome with plasma exchange therapy and tocilizumab : a case report","\u9ad8\u7528\u91cf\u30b0\u30eb\u30b3\u30b3\u30eb\u30c1\u30b3\u30a4\u30c9\uff0c\u30b7\u30af\u30ed\u30b9\u30dd\u30ea\u30f3\u6cbb\u7642\u4e2d\u306b\u8840\u7403\u8caa\u98df\u75c7\u5019\u7fa4\u3092\u767a\u75c7\u3057\u8840\u6f3f\u4ea4\u63db\u7642\u6cd5\u3068\u30c8\u30b7\u30ea\u30ba\u30de\u30d6\u304c\u594f\u529f\u3057\u305f\u6210\u4eba\u767a\u75c7Still\u75c5\u306e\u4e00\u4f8b"],"prefix":"10.2177","volume":"36","author":[{"given":"Yoji","family":"KOMIYA","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Ome municipal general hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenchi","family":"TAKENAKA","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ome municipal general hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"NAGASAKA","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Ome municipal general hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","unstructured":"1) Yamaguchi, M., et al. : Preliminary criteria for classification of adult Still's disease. <i>J Rheumatol<\/i>. <b>19<\/b> : 424-430, 1992."},{"key":"2","unstructured":"2) Arlet, JB., et al. : Reactive hemophagocytic syndrome in adult-onset Still's disease : a report of six patients and a review of the literature. <i>Ann Rheum Dis<\/i>. <b>65<\/b> : 1596-1601, 2006."},{"key":"3","unstructured":"3) Fautrel, B., et al. : Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease. <i>J Rheumatol<\/i>. <b>26<\/b> : 373-378, 1999."},{"key":"4","unstructured":"4) Marchesoni, A., et al. : Cyclosporin A in the treatment of adult onset Still's disease. <i>J Rheumatol<\/i>. <b>24<\/b> : 1582-1587, 1997."},{"key":"5","unstructured":"5) Murakami, K., et al. : Successful treatment of a patient with refractory adult Still's disease by tacrolimus. <i>Mod Rheumatol<\/i>. <b>17<\/b> : 167-170, 2007."},{"key":"6","unstructured":"6) Kraetsch, HG., et al. : Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. <i>Ann Rheum Dis<\/i>. 60 (Suppl 3) : iii55-iii57, 2001."},{"key":"7","unstructured":"7) Pu&eacute;chal, X., et al. : Tocilizumab in refractory adult Still's disease. <i>Arthritis Care Res<\/i>. <b>63<\/b> : 155-159, 2011."},{"key":"8","unstructured":"8) Kaneko, K., et al. : Exacerbation of adult-onset Still's disease, possibly related to elevation of serum tumor necrosis factor-alpha after etanercept administration. <i>Int J Rheum Dis<\/i>. <b>13<\/b> : 67-69, 2010."},{"key":"9","unstructured":"9) Kato, T., et al. : Double-filtration plasmapheresis for resolution of corticosteroid resistant adult onset Still's disease. <i>Clin Rheumatol<\/i>. <b>25<\/b> : 579-582, 2006."},{"key":"10","unstructured":"10) Kuek, A., et al. : Adult-onset Still's disease and myocarditis : successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. <i>Rheumatology (Oxford)<\/i>. <b>46<\/b> : 1043-1044, 2007."},{"key":"11","unstructured":"11) Fautrel, B., et al. : Tumour necrosis factor alpha blocking agents in refractory adult Still's disease : an observational study of 20 cases. <i>Ann Rheum Dis<\/i>. <b>64<\/b> : 262-266, 2005."},{"key":"12","unstructured":"12) Boysson, H., et al. : Tocilizumab in the treatment of the adult-onset Still's disease : current clinical evidence. <i>Clin Rheumatol<\/i>. <b>32<\/b> : 141-147, 2013."},{"key":"13","unstructured":"13) Maeshima, K., et al. : Adult-onset Still's disease with macrophage activation syndrome successfully treated with a combination of methotrexate and etanercept. <i>Mod Rheumatol<\/i>. <b>22<\/b> : 137-141, 2012."},{"key":"14","unstructured":"14) Kobayashi, M., et al. : Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome. <i>Mod Rheumatol<\/i>. <b>21<\/b> : 92-96, 2011."},{"key":"15","unstructured":"15) Stern, A., et al. : Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy. <i>J Clin Rheumatol<\/i>. <b>7<\/b> : 252-256, 2001."},{"key":"16","unstructured":"16) Fautrel, B. : Adult-onset Still disease. <i>Best Pract Res Clin Rheumatol<\/i>. <b>22<\/b> : 773-792, 2008."},{"key":"17","unstructured":"17) Yoshizaki, A., et al. : Preferential recovery by an intensive initial therapy from hemophagocytic syndrome complicated with adult onset Still's disease presenting as agranulocytosis and hypercytokinemia. <i>Clin Exp Rheumatol<\/i>. <b>26<\/b> : 383, 2008."},{"key":"18","unstructured":"18) Shimizu, M., et al. : Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome : the diagnostic significance of interleukin-18 and interleukin-6. <i>Cytokine<\/i>. <b>58<\/b> : 287-294, 2012."},{"key":"19","unstructured":"19) Nishida, T., et al. : Hemophagocytic syndrome and adult Still's disease associated with meningoencephalitis and unconsciousness. <i>Intern Med<\/i>. <b>40<\/b> : 1037-1040, 2001."},{"key":"20","unstructured":"20) Ito, T., et al. : Successful treatment with plasma exchange in adult-onset Still's disease with hyper-IL-18-naemia and hyperallergic state. <i>Mod Rheumatol<\/i>. <b>18<\/b> : 407-410, 2008."},{"key":"21","unstructured":"21) Kettelhack, C., et al. : Induction of systemic serum procalcitonin and cardiocirculatory reactions after isolated limb perfusion with recombinant human tumor necrosis factor-alpha and melphalan. <i>Crit Care Med<\/i>. <b>28<\/b> : 1040-1046, 2000."},{"key":"22","unstructured":"22) Chen, DY., et al. : Diagnostic value of procalcitonin for differentiation between bacterial infection and non-infectious inflammation in febrile patients with active adult-onset Still's disease. <i>Ann Rheum Dis<\/i>. <b>68<\/b> : 1074-1075, 2009."},{"key":"23","unstructured":"23) Ames, PR., et al. : Multi-organ failure in adult onset Still's disease : a septic disguise. <i>Clin Rheumatol<\/i>. <b>28<\/b> : S3-6, 2009."},{"key":"24","unstructured":"24) Scir&eacute;, CA., et al. : Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases. <i>Clin Exp Rheumatol<\/i>. <b>24<\/b> : 123-128, 2006."}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/6\/36_478\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T04:54:10Z","timestamp":1621486450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/36\/6\/36_478\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.36.478","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}